Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2001 May 1;164(9):1309-16.

New advances in the management of acute coronary syndromes: 1. Matching treatment to risk

D Fitchett  1 , S Goodman, A Langer
Affiliations
Case Reports

New advances in the management of acute coronary syndromes: 1. Matching treatment to risk

D Fitchett et al. CMAJ. .
No abstract available

PubMed Disclaimer

Figures

None
Fig. 1: Diagnostic triage and management of patients presenting to the emergency department with chest pain and a clinical suspicion of an acute coronary syndrome (unstable angina or myocardial infarction). CCU = coronary care unit, GP IIb/IIIa = glycoprotein IIb/IIIa inhibitor, LMW = low-molecular-weight. Photo by: Christine Kenney
None
Fig. 2: Six-month mortality among patients with an acute coronary syndrome, by electrocardiogram result at time of presentation. Although patients with ST-segment depression (ST↓) have a better early (5-day) survival than those with ST-segment elevation (ST↑), their long-term outlook is as bad, if not worse. In this study patients at lowest risk were those with T-wave inversion alone. [Adapted, with permission, from Savonitto et al, JAMA 1999;281:707-13. Copyrighted 1999, American Medical Assocation.]
None
Fig. 3: Mortality in relation to cardiac troponin levels at time of randomization. Left: Troponin I, in TIMI IIIB study [adapted, with permission, from Antman et al, N Engl J Med 1996;335:1342-9]. Right: Troponin T, in GUSTO-IIa study [adapted, with permission, from Ohman et al, N Engl J Med 1996;335:1333-41].
None
Fig. 4: Cumulative survival during the 360 days following acute coronary syndrome (ACS) with non-ST-segment elevation ACS in patients with refractory myocardial ischemia. [Adapted, with permission, from Armstrong et al, Circulation 1998;98:1860-8.]
None
Fig. 5: Risk stratification of patients presenting with a non-ST-segment elevation acute coronary syndrome (ACS). Identification of high-, intermediate- and low-risk categories allows appropriate management choices. [Adapted, with permission, from Fitchett, Can J Cardiol 2000;16:1423-32.]
See this image and copyright information in PMC

Comment in

References

    1. Rahimtoola SH. Coronary bypass surgery for unstable angina. Circulation 1984; 69:842-8. - PubMed
    1. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994;343:311-22. - PubMed
    1. Rude RE, Poole WK, Muller JE, Turi Z, Rutherford J, Parker C, et al. Electrocardiographic and clinical criteria for the recognition of acute myocardial infarction based on analysis of 3,697 patients. Am J Cardiol 1983;52:936-42. - PubMed
    1. Margolis JR, Kannel WS, Feinleib M, Dawber TR, McNamara PM. Clinical features of unrecognized myocardial infarction — silent and symptomatic. Eighteen year follow-up: the Framingham study. Am J Cardiol 1973;32:1-7. - PubMed
    1. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham study. N Engl J Med 1984;311:1144-7. - PubMed

Publication types

MeSH terms